These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2859276

  • 1. Antipsychotic drug side effects: their relationship to dose.
    Kane JM.
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):16-21. PubMed ID: 2859276
    [Abstract] [Full Text] [Related]

  • 2. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [Abstract] [Full Text] [Related]

  • 3. Partial response to antipsychotic treatment: the patient with enduring symptoms.
    Emsley RA.
    J Clin Psychiatry; 1999 May; 60 Suppl 23():10-3. PubMed ID: 10625194
    [Abstract] [Full Text] [Related]

  • 4. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG, Milstein V, Marhenke JD, Hall DD, Kellams JJ.
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM, Cellar JS, Bowers MB, Nelson JC, Takeshita J, Zigun B.
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Depot fluphenazine: risk/benefit ratio.
    Glazer WM.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A.
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [Abstract] [Full Text] [Related]

  • 16. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
    Ben Hadj Ali B, Dogui M, Ben Ammou S, Lôo H.
    Encephale; 1995 Oct; 21(3):209-15. PubMed ID: 7649071
    [Abstract] [Full Text] [Related]

  • 17. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 18. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
    McManus DQ, Arvanitis LA, Kowalcyk BB.
    J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
    [Abstract] [Full Text] [Related]

  • 19. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
    Dose M.
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.